Z
Zhiyuan Zhong
Researcher at Soochow University (Suzhou)
Publications - 359
Citations - 26501
Zhiyuan Zhong is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Medicine & Micelle. The author has an hindex of 76, co-authored 325 publications receiving 23337 citations. Previous affiliations of Zhiyuan Zhong include Ludwig Maximilian University of Munich & Academia Sinica.
Papers
More filters
Journal ArticleDOI
Polymers from Nature and for Nature
TL;DR: The interplay between polymer science and nature, which has grown quickly and diversified over the past years, is marked by some of the most exciting research that is being carried out in Asian countries such as China, India, Japan, Korea, and Singapore.
Journal ArticleDOI
External stimuli-responsive gasotransmitter prodrugs: Chemistry and spatiotemporal release.
Xing Yue Ji,Zhiyuan Zhong +1 more
TL;DR: In this article , the authors highlight the recent development of external stimuli-mediated decaging chemistry for the temporospatial delivery of gasotransmitters including nitric oxide, carbon monoxide, hydrogen sulfide and sulfur dioxide, and discuss the pros and cons of different designs.
Journal ArticleDOI
Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice
TL;DR: ApoE-PS-DOX with varying amount of ApoE (10~30 mol%) all had stable DOX loading and small sizes (< 90 nm.
Journal ArticleDOI
Redox-sensitive iodinated polymersomes carrying histone deacetylase inhibitor as a dual-functional nano-radiosensitizer for enhanced radiotherapy of breast cancer.
Zhehong Zhu,Manran Wu,Juan Sun,Zhengyuan Huangfu,Lingling Yin,Weipeng Yong,Jing Sun,Guanglin Wang,Fenghua Meng,Zhiyuan Zhong +9 more
TL;DR: The outcome of radiotherapy varies, however, to a great extent, due to RT resistance or intolerable dose, which might be resolved by... as discussed by the authors, which is a frequently used means in clinical tumor treatment.
Journal ArticleDOI
Polymeric nanomedicines targeting hematological malignancies.
TL;DR: In this article, the authors highlight recent advance in targeted polymeric nano-formulations that are coated with varying ligands (e.g. cancer cell membrane proteins, antibodies, transferrin, hyaluronic acid, aptamer, peptide, and folate) and loaded with different therapeutic agents (i.e. chemotherapeutics, molecular targeted drugs, therapeutic antibodies, nucleic acid drugs, and apoptotic proteins) for directing to distinct targets (e